Tuesday, April 30, 2019

Integrin a10 - a new target for glioblastomas

As we have discussed before,


getting after glioblastoma is hard.  Here a group from Lund Sweden has identified a new potential target for ADC therapeutics.


The preliminary results look very encouraging, however the fact remains, that if curing cancer in humans was as easy as curing cancer in mice, cancer would have been eliminated a long time ago.

What do you think?  Are these types of discoveries things to get excited about? Seeds for a new biotech company?  Or just another academic discovery with no application in the real world?

No comments:

Post a Comment